Searched for
FUNDS BLOCKING
Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...- HDFC raises $750-m ECB, first under RBI's special swap planHDFC Bank has successfully raised $750 million in offshore bonds, marking the first to leverage the RBI's 1.5% fixed-rate swap for external...
- Peak XV, Nexus set for 7-9x returns from Turtlemint IPO share saleTurtlemint has set a price band of Rs 144-152 per share for its Rs 883 crore IPO, which opens on June 19. The IPO comprises a fresh issue o...
- HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block dealSepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged...
- What should international students know about Germany's blocked account requirement?Germany requires international students and job seekers to open a blocked account, known as a Sperrkonto, to prove financial self-sufficien...
- Startup investors cash out nearly Rs 18,000 crore after IPO lock-ins endTop global investors like SoftBank and KKR have cashed out nearly Rs 18,000 cr from new-age Indian companies post-listing. This marks a shi...
- Bank freezes Bengaluru man's entire account instead of Rs 25,000 specified by police; Karnataka HC grants him reliefA Bengaluru resident approached the Karnataka High Court after his bank froze his entire account despite police communications seeking a fr...
- Sarvam joins unicorn club; Razorpay lines up IPOFresh funding has propelled Sarvam AI into the unicorn club. This and more in today’s ETtech Top 5.
- How will the UK ban on social media for under 16s work?Prime Minister Keir Starmer intends to ban social media platforms for children under sixteen. This move aims to protect young people's chil...
- Global Markets: AI supply chain bets propel Asian hedge funds to stellar performanceAsia-focused hedge funds delivered outsized returns in 2026 by riding the artificial intelligence boom across semiconductors and related te...
- Lenskart block deal; Meesho's kirana pushLenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.
- Iran media says draft US deal sees release of $24 billion frozen assetsA draft deal between Iran and the United States has been published. This agreement could lead to the release of 24 billion dollars in froze...
- ₹50 lakh to ₹1.4 crore: How extending your PPF can add lakhs to your corpus and who should do itPPF maturity presents a choice: withdraw or extend for continued tax-free compounding. While government backing and tax benefits remain att...
- Lenskart shares in focus as Goldman Sachs, Morgan Stanley, others purchase stake in Rs 1,960 crore block dealLenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...
- Goldman Sachs, Morgan Stanley and others buy stake in Rs 1,960 crore Lenskart block dealADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...
- Lenskart Solutions sees Rs 1,862-crore block deal; ADIA likely sellerEyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...
- ADIA to sell 2.3% Lenskart stake in Rs 1,944 crore block dealAbu Dhabi Investment Authority is set to divest a 2.3% stake in Lenskart for approximately Rs 1,944 crore via a block deal. This follows So...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
